Kouseiren Takaoka Hospital

Gefitinib versus cisplatin plus docetaxel in patients with non-small-cell lung cancer harbouring mutations of the epidermal growth factor receptor (WJTOG3405): an open label, randomised phase 3 trial

Tetsuya Mitsudomi, Satoshi Morita, Yasushi Yatabe et al. · The Lancet Oncology · 2009 · 4.1K citations

Open Label, Medicine, Cancer Growth +10

S-1 plus cisplatin versus S-1 alone for first-line treatment of advanced gastric cancer (SPIRITS trial): a phase III trial

Wasaburo Koizumi, Hiroyuki Narahara, Takuo Hara et al. · The Lancet Oncology · 2008 · 1.9K citations

Surgical Oncology, Spirits Trial, Gastrointestinal Oncology +8

IgG4-related Sclerosing Cholangitis With and Without Hepatic Inflammatory Pseudotumor, and Sclerosing Pancreatitis-associated Sclerosing Cholangitis

Yoh Zen, Kenichi Harada, Motoko Sasaki et al. · The American Journal of Surgical Pathology · 2004 · 538 citations

Pancreatitis-associated Sclerosing Cholangitis, Immunology, Gastroenterology +21

Biliary papillary tumors share pathological features with intraductal papillary mucinous neoplasm of the pancreas

Yoh Zen, Takahiko Fujii, Keita Itatsu et al. · Hepatology · 2006 · 391 citations · Full text

Abundant IgG4-Positive Plasma Cell Infiltration Characterizes Chronic Sclerosing Sialadenitis (Küttner's Tumor)

Satoshi Kitagawa, Yoh Zen, Kenichi Harada et al. · The American Journal of Surgical Pathology · 2005 · 370 citations · Full text